OR WAIT null SECS
October 10, 2024
At this year's CPHI Milan, Camille Dumont, PhD, manager, customer applications, Lonza, discussed current industry trends that are impacting oral solid dose formulation work.
September 13, 2024
The critical APIs that this funding will contribute to are used in the treatment of asthma, diabetes, and anxiety disorders.
July 03, 2024
This collaboration aims to support and accelerate clinical development of advanced and novel technologies.
August 22, 2023
The collaboration partner for Willow is focused on more sustainable methods to manufacture intermediates and APIs at reduced cost and less waste, in addition to looking for Willow’s expertise in developing and scaling key ingredients.
May 16, 2023
Outsourcing collaborations provide insight into the key drivers of market growth.
January 18, 2023
Snapdragon Chemistry concentrates in API batch and continuous flow process development, utilizing state-of-the-art automation technology and proprietary equipment to solve complex process and analytical development challenges.
Agilent’s $725 million investment is designed to double its capacity to produce APIs.
October 25, 2022
June 09, 2022
Following the acquisition by Altaris Capital Partners, Johnson Matthey Health has rebranded as Veranova.
May 26, 2022
Lonza and Israel Biotech Fund form a two-year agreement to support accelerated development and manufacture of biologics and small molecules.